Direct Biologics
exit covid phase trial results comparison | Direct Biologics
Company
Deck Type
Deck date
October 2022
Slide
23 of 36
Related slides by other companies
Ocuphire Pharma
Results
March 2022
comparison of one drop fellow eye with two drops study eye | Ocuphire Pharma
ATAI
Investor Presentation
November 2022
milestone highlights in anticipated catalysts across we will build on recent success by delivering several meaningful our key programs | ATAI
ATAI
Investor Presentation
June 2020
milestone highlights in anticipated catalysts across we will build on recent success by delivering several meaningful our key programs | ATAI
ATAI
Investor Presentation
October 2023
in cash as of provides expected runway into life sciences operational focus program guidance | ATAI
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights